Preoperative antimicrobial administration for prevention of postoperative infection in patients with laparoscopic cholecystectomy

被引:28
作者
Uchiyama, K [1 ]
Kawai, M [1 ]
Onishi, H [1 ]
Tani, M [1 ]
Kinoshita, H [1 ]
Ueno, M [1 ]
Yamaue, H [1 ]
机构
[1] Wakayama Med Univ, Sch Med, Dept Surg 2, Wakayama 6418510, Japan
关键词
laparoscopic cholecystectomy; beta-lactamase; surgical site infection; antimicrobial prophylaxis; biliary infection;
D O I
10.1023/A:1026114203622
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The present study was designed to investigate whether the administration of antimicrobial agents before laparoscopic cholecystectomy (LC) is more effective for prevention of postoperative infection. During the period from January 1991 to September 2001, 397 patients treated with sulbactam/ cefoperazone (SBT/CPZ) for prevention of postoperative infection were studied: 200 patients received SBT/CPZ 1 hr before LC, and 197 patients were not given the preoperative treatment. The positive rate of bacteria in the gallbladder bile in the group receiving preoperative SBT/CPZ was 12.0%, a significant suppression compared with 19.8% in the group without preoperative treatment (P < 0.05). Identification of microorganisms in the bile revealed E. coli and Klebsiella in the preoperative treatment group, which showed a significant suppression ( P < 0: 05). The mean white blood cell count was significantly lower in the preoperative treatment group (9860/mul) than in the nonpreoperative treatment group (10,520/mul) (P < 0.05). The above results demonstrate that administration of SBT/CPZ before LC suppressed the level of bacteria in the bile, resulting in a significant reduction in complications induced by postoperative infection.
引用
收藏
页码:1955 / 1959
页数:5
相关论文
共 14 条
[1]
[Anonymous], 1982, infect control
[2]
THE TIMING OF PROPHYLACTIC ADMINISTRATION OF ANTIBIOTICS AND THE RISK OF SURGICAL-WOUND INFECTION [J].
CLASSEN, DC ;
EVANS, RS ;
PESTOTNIK, SL ;
HORN, SD ;
MENLOVE, RL ;
BURKE, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (05) :281-286
[3]
Farello G A, 2000, J Chemother, V12 Suppl 3, P17
[5]
THE EFFECT OF OBSTRUCTION ON THE BILIARY-EXCRETION OF CEFOPERAZONE AND CEFTAZIDIME [J].
LEUNG, JWC ;
CHAN, RCY ;
CHEUNG, SW ;
SUNG, JY ;
CHUNG, SCS ;
FRENCH, GL .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (03) :399-406
[6]
Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: Results of a randomized, controlled clinical trial [J].
Li, JT ;
Lu, Y ;
Hou, J ;
Chen, YF ;
Miao, JZ ;
Jia, YX ;
Hou, J ;
Zhang, XZ ;
Chen, DK ;
Hu, WZ ;
Li, LJ ;
Liu, DM ;
Wang, Z ;
Wu, J ;
Gu, JM ;
Wang, HL ;
Zhang, YL ;
Sun, L .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (03) :498-505
[7]
Antimicrobial prophylaxis in laparoscopic and conventional cholecystectomy - Conclusions of a large prospective multicenter quality assurance study in Germany [J].
Lippert, H ;
Gastinger, J .
CHEMOTHERAPY, 1998, 44 (05) :355-363
[8]
Guideline for Prevention of Surgical Site Infection, 1999 [J].
Mangram, AJ ;
Horan, TC ;
Pearson, ML ;
Silver, LC ;
Jarvis, WR .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (04) :250-278
[9]
PENETRATION OF CEFTRIAXONE AND CEFOPERAZONE INTO BILE AND GALLBLADDER TISSUE IN PATIENTS WITH ACUTE CHOLECYSTITIS [J].
ORDA, R ;
BERGER, SA ;
LEVY, Y ;
SHNAKER, A ;
GOREA, A .
DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (11) :1691-1693
[10]
PAGE CP, 1993, ARCH SURG-CHICAGO, V128, P79